Photo via The Straits Times

White House pulls FDA chief nominee Heidi Overton before hearing, Axios says

Read the original at The Straits Times ↗
Cite

The Straits Times. (2026, November 18). White House pulls FDA chief nominee Heidi Overton before hearing, Axios says. The Straits Times. https://www.straitstimes.com/world/united-states/white-house-pulls-fda-chief-nominee-heidi-overton-before-hearing-axios-says

Dated from the outlet's own feed. Check the original for its byline.

The Straits Times · collected 2026-11-18 · by The Straits Times

Quick Summary

The White House has withdrawn Heidi Overton’s nomination to lead the US Food and Drug Administration (FDA) before her confirmation hearing, according to Axios. The decision was made due to a lack of congressional support, especially after criticism from a former Health Secretary’s adviser and opposition from several Republican senators. This move adds to the FDA’s ongoing leadership challenges, with the agency currently led temporarily by Kyle Diamantas.
Written by AI on 2026-11-18, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

How they differ

11 outlets covered “White House withdraws Heidi Overton’s nomination to become”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

The Straits TimesThis outlet18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the US Food and Drug Administration (FDA) before her confirmation hearing, according to Axios. The decision was made due to a lack of congressional support, especially after criticism from a former Health Secretary’s adviser and opposition from several Republican senators. This move adds to the FDA’s ongoing leadership challenges, with the agency…

White House pulls FDA chief nominee Heidi Overton before hearing, Axios says (this article)
CBS News18 Nov

The White House has withdrawn Dr. Heidi Overton's nomination as the new FDA commissioner, a position she was selected for by President Trump. The Senate health committee was set to vote on her nomination on Wednesday, but the White House has since decided to remove her from consideration. Axios was the first to report this change.

White House drops Heidi Overton's nomination for FDA commissioner →2 articles from CBS News on this story
New York Post18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the Food and Drug Administration (FDA) due to insufficient support from Senate lawmakers. Overton, a physician and deputy director of the White House Domestic Policy Council, faced significant opposition for her alleged ties to the tobacco industry, pro-vaping stance, and anti-abortion views. Critics demonstrated their disapproval by placing signs…

White House withdraws Heidi Overton’s FDA nomination after Trump pick received bipartisan pushback →
Toronto Star18 Nov

The White House has withdrawn Dr. Heidi Overton’s nomination to lead the Food and Drug Administration due to insufficient Senate Republican support. Overton, a Trump-aligned physician and White House domestic policy adviser, was nominated in August to replace Dr. Marty Makary, who had a controversial tenure. Her nomination was intended to stabilize the FDA with a Trump loyalist, but faced opposition that prevented…

White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans →
NBC News18 Nov

The White House has withdrawn Dr. Heidi Overton’s nomination to become the FDA commissioner due to Republican senators' concerns about her lack of managerial experience. The decision came shortly before Overton’s scheduled Senate Health Committee vote, where she needed at least one Republican vote to advance. Senators Cassidy, Collins, and Murkowski expressed reservations about Overton’s qualifications and her…

White House drops Heidi Overton’s FDA nomination →
Show 5 more outlets
ABC News (US)18 Nov

Dr. Heidi Overton's nomination to become the FDA commissioner was withdrawn on Tuesday after facing significant opposition from some Republican senators. The nomination encountered hurdles primarily due to Overton’s positions on abortion, vaccines, and vaping, according to sources familiar with the situation.

Trump's pick Heidi Overton dropped as nominee for FDA commissioner →
Just the News18 Nov

The White House has withdrawn Heidi Overton's nomination to lead the Food and Drug Administration (FDA) just one day before her scheduled vote by the Senate Health, Education, Labor and Pensions Committee. Overton, a physician and deputy director of the White House Domestic Policy Council, faced skepticism from some Republicans about her involvement in changing childhood vaccine recommendations. A senior…

White House pulls Heidi Overton's nomination to lead Food and Drug Administration: Report →
The Guardian18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the Food and Drug Administration after bipartisan concerns about her willingness to challenge President Trump’s policies, particularly regarding vaccines and abortion. Republican senator Bill Cassidy, who chairs the Senate health committee, had expressed reservations about her support for Trump’s vaccine plans and her stance on abortion rights…

White House withdraws nomination of Heidi Overton to lead FDA →
Daily Caller18 Nov

The Trump administration withdrew Heidi Overton’s nomination to lead the FDA on November 18, 2026, due to lack of support in the Senate. Overton, a physician and deputy director of the White House Domestic Policy Council, was nominated in August and faced opposition from Democrats, some Republicans, and MAHA activists. The White House cited the need for a more populist approach to health as the reason for the…

MAHA Rejoices After White House Drops Controversial FDA Nomination →

Where they agree and split

Framing

How the first headlines put it

Attributed to a source2
Stated as fact8
The headlines (10)

White House pulls FDA chief nominee Heidi Overton before hearing, Axios says The Straits Times · attributed to a source

White House pulls Heidi Overton's nomination to lead Food and Drug Administration: Report Just the News · attributed to a source

Trump FDA nominee Heidi Overton struggling to win GOP support CBS News · stated as fact

White House withdraws Heidi Overton’s FDA nomination after Trump pick received bipartisan pushback New York Post · stated as fact

White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans Toronto Star · stated as fact

White House drops Heidi Overton’s FDA nomination NBC News · stated as fact

White House pulls Trump’s FDA pick Heidi Overton on eve of Senate panel vote Fox News · stated as fact

Trump's pick Heidi Overton dropped as nominee for FDA commissioner ABC News · stated as fact

White House withdraws nomination of Heidi Overton to lead FDA The Guardian · stated as fact

White House withdraws Heidi Overton’s nomination to become next FDA commissioner Washington Examiner · stated as fact

The full story: what happened, how it changed, and all 12 articles →

Compared with similar articles

This article reads unscored and hedges 18% of its claims. Each row says how that neighbour differs.
New York Post
Leans left Hedges 0 of 7 claims Outlet record 66/100
The Guardian
Leans right Hedges 1 of 18 claims Outlet record 64/100
NBC News
Leans right Hedges 1 of 19 claims Outlet record 78/100
Washington Examiner
Hedges 0 of 2 claims Outlet record 67/100
CBS News
Hedges 1 of 4 claims Outlet record 67/100
Toronto Star
Leans right Hedges 0 of 3 claims Outlet record 64/100
ABC News (US)
Leans right Hedges 0 of 4 claims Outlet record 67/100

Story

White House withdraws Heidi Overton’s nomination to become
Other · 12 article(s) covering the same event. Compare every outlet's account →
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
17
sentences that state something as happening or true
Uncertain
18%
3 of 17 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
64/100
The Straits Times's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
12
Other
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-18 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

The Straits Times · 5423 article(s) · 7 correction(s) detected
Running correction rate · 7 correction(s)

Who wrote this

The Straits Times
3768 article(s) here · 1 carrying a prediction
“We will always protect our national interests and ensure that there are guardrails in place,” she added, when asked about the prospect of Chinese automakers stepping up investment in production plants in Canada as well as in the North American country’s energy sector.
Trump then pointed to Takaichi, saying, “And she may be even tougher.”
Rubio says no imminent threat to Washington after report of possible Iranian dirty bomb plot AI generated MANILA/ WASHINGTON – US Secretary of State Marco Rubio said on Nov 18 he did not think there was any imminent threat to the US capital, when asked about a CNN report citing US intelligence assessments on the possibility that Iran may be planning an attack involving a so-called dirty bomb in Washington.
Instantly recognisable for the red spots it generates on an infected person’s body, measles also causes fever, respiratory symptoms, and in some cases more serious complications such as pneumonia and brain inflammation, which can lead to severe long-term health problems or even death. ‘The worst illness’ Jones said measles patients are usually “extremely miserable”, adding “it is often the worst illness the child will have ever gone through in their life”.
They also argued the ballot was designed to distinguish the two Sullivans as much as possible and that Alaska’s ranked choice voting process would allow any voters who might be confused to rank them.
CNN cited seven anonymous US officials as saying Iran was plotting how to target senior administration figures with a bomb laced with chemical or radioactive material, though they stopped short of saying Iran planned to carry out such an attack. “If there is (such a threat), they will pay a price the likes of which no other country has ever paid before,” Trump said.
The US has even asked Kyiv whether it would cede its Donbas region to Russia in exchange for membership in the NATO military alliance.
Other recent developments may further encourage international applicants.
The Java discovery may be Calif’s most serious yet, one that could enable a hacker to gain remote access to sensitive internal systems.
China warned the US it would retaliate if Washington proceeds with curbs on remote access to advanced chips, while urging the Trump administration to resolve differences through dialogue.
Also by The Straits Times
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 3768 articles by The Straits Times →

Topics

Axios FDA Senate The White House White House

Subjects

FDA ORG · 5× Overton PERSON · 5× Axios ORG · 3× White House ORG · 3× Heidi Overton PERSON · 2× Means PERSON · 2× Republican NORP · 2× Senate ORG · 2× The White House ORG · 2× Trump PERSON · 2×

Narrative

Maine Republican Senator Susan Collins said she had concerns about the FDA’s authorisation of fruit-flavoured vapes earlier in 2026 and Alaska Senator Lisa Murkowski expressed concerns about the agency’s approach to the abortion pill mifepristone.
framing: assertive · carried by 1 article(s) · first seen 2026-11-18
The withdrawal will extend a period of turmoil at the FDA, which regulates products that account for roughly a fifth of consumer spending in the US.
2026-11-18 · The Straits Times
White House pulls FDA chief nominee Heidi Overton before hearing, Axios says · assertive framing

Claims (17 extracted, 3 hedged)

White House pulls FDA chief nominee Heidi Overton before hearing, Axios says AI generated WASHINGTON – asserted
Axios → pull → hearing
The Trump administration has withdrawn White House aide Heidi Overton’s nomination to lead the US Food and Drug Administration (FDA), according to Axios, leaving the agency without a permanent commissioner as the political path to filling the post grows more complicated. uncertain
path → withdraw → post
The White House has dropped the bid due to lack of congressional support, Axios said, citing an unnamed senior administration official. asserted
Axios → drop → official
The Senate Health, Education, Labour and Pensions committee was slated to vote on Nov 18 whether to recommend Overton for a full floor vote. asserted
committee → slat → vote
She was the target of criticism from Calley Means, who recently left his job as one of Health Secretary Robert F. Kennedy Jr.’s top advisers. asserted
who → leave → advisers
In a scorched-earth campaign following his departure, Means claimed Overton opposed Kennedy’s policy goals on pesticides, food policy, vaccines and psychedelic treatments. asserted
Overton → scorch → pesticides
Senator Bill Cassidy, a Louisiana Republican who leads the Senate HELP committee, criticised Overton for helping craft President Donald Trump’s executive order proposing an overhaul of childhood vaccinations. asserted
who → lead → vaccinations
Maine Republican Senator Susan Collins said she had concerns about the FDA’s authorisation of fruit-flavoured vapes earlier in 2026 and Alaska Senator Lisa Murkowski expressed concerns about the agency’s approach to the abortion pill mifepristone. asserted
Murkowski → say → pill
The withdrawal will extend a period of turmoil at the FDA, which regulates products that account for roughly a fifth of consumer spending in the US. asserted
that → extend → US
Former Commissioner Marty Makary resigned in May after 13 months in the top role that were marred by clashes with staff and pushback from biotech companies. uncertain
that → resign → companies
Soon after, a wave of other senior leaders departed. asserted
wave → depart → leaders
It’s unclear whether the White House will be able to advance a nominee before Democrats take control of the Senate in January. uncertain
Democrats → ’ → January
Attorney Kyle Diamantas, who previously headed the agency’s food centre, is leading the FDA on a temporary basis. asserted
who → head → basis
The Trump administration has had several high-profile failed nominations for top health positions, including two for surgeon general and one to lead the Centres for Disease Control and Prevention. asserted
administration → have → Control
The surgeon general role remains unfilled; Erica Schwartz took the helm at CDC in August. asserted
Schwartz → remain → August
Overton is a deputy assistant to the president for domestic policy, focused on health issues. asserted
Overton → focus → issues
She worked at the think tank America First Policy Institute, is a medical doctor and has a doctorate in clinical investigation from Johns Hopkins University. asserted
She → work → University
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support